Patients Taking Anti-Inflammatory Drugs Respond Less Well to COVID-19 Vaccine
(NYU Langone Health / NYU Grossman School of Medicine) One-quarter of people who take the drug methotrexate for common immune system disorders -- from rheumatoid arthritis to multiple sclerosis -- mount a weaker immune response to a COVID-19 vaccine, a new study shows.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Arthritis | COVID-19 | Infectious Diseases | Methotrexate | Multiple Sclerosis | Rheumatoid Arthritis | Rheumatology | Study | Vaccines